AU2003237945A1 - Crystalline (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl)-benzimidazole, and the use thereof as antithrombotic agents - Google Patents
Crystalline (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl)-benzimidazole, and the use thereof as antithrombotic agentsInfo
- Publication number
- AU2003237945A1 AU2003237945A1 AU2003237945A AU2003237945A AU2003237945A1 AU 2003237945 A1 AU2003237945 A1 AU 2003237945A1 AU 2003237945 A AU2003237945 A AU 2003237945A AU 2003237945 A AU2003237945 A AU 2003237945A AU 2003237945 A1 AU2003237945 A1 AU 2003237945A1
- Authority
- AU
- Australia
- Prior art keywords
- amidinophenylaminomethyl
- pyrrolidinocarbonyl
- carboxymethylamino
- benzimidazole
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10227666.8 | 2002-06-20 | ||
DE10227666A DE10227666A1 (en) | 2002-06-20 | 2002-06-20 | (R) -2- (4-amidinophenylaminomethyl) -1-methyl-5- [1- (carboxymethylamino) -1- (pyrrolidinocarbonyl) ethyl] benzimidazole, its monohydrochloride, process for its preparation and use as a medicament |
PCT/EP2003/006317 WO2004000818A1 (en) | 2002-06-20 | 2003-06-16 | Crystalline (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl)-benzimidazole, and the use thereof as antithrombotic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003237945A1 true AU2003237945A1 (en) | 2004-01-06 |
Family
ID=29719306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003237945A Abandoned AU2003237945A1 (en) | 2002-06-20 | 2003-06-16 | Crystalline (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl)-benzimidazole, and the use thereof as antithrombotic agents |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1529035A1 (en) |
JP (1) | JP2006508037A (en) |
AR (1) | AR040445A1 (en) |
AU (1) | AU2003237945A1 (en) |
CA (1) | CA2485545A1 (en) |
DE (1) | DE10227666A1 (en) |
TW (1) | TW200413329A (en) |
UY (1) | UY27856A1 (en) |
WO (1) | WO2004000818A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2655399B1 (en) | 2010-12-21 | 2017-09-27 | The Medicines Company (Leipzig) GmbH | Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI248435B (en) * | 1998-07-04 | 2006-02-01 | Boehringer Ingelheim Pharma | Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions |
DE19962329A1 (en) * | 1999-12-23 | 2001-06-28 | Boehringer Ingelheim Pharma | New substituted 2-(phenylaminomethyl)-benzimidazoles, used as thrombin inhibitors, serine protease inhibitors, antithrombotic agents and intermediates |
-
2002
- 2002-06-20 DE DE10227666A patent/DE10227666A1/en not_active Withdrawn
-
2003
- 2003-06-16 WO PCT/EP2003/006317 patent/WO2004000818A1/en active Application Filing
- 2003-06-16 CA CA002485545A patent/CA2485545A1/en not_active Abandoned
- 2003-06-16 JP JP2004514726A patent/JP2006508037A/en active Pending
- 2003-06-16 AU AU2003237945A patent/AU2003237945A1/en not_active Abandoned
- 2003-06-16 EP EP03735629A patent/EP1529035A1/en not_active Withdrawn
- 2003-06-18 UY UY27856A patent/UY27856A1/en not_active Application Discontinuation
- 2003-06-19 TW TW092116667A patent/TW200413329A/en unknown
- 2003-06-20 AR AR20030102210A patent/AR040445A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
TW200413329A (en) | 2004-08-01 |
UY27856A1 (en) | 2003-12-31 |
DE10227666A1 (en) | 2004-01-08 |
JP2006508037A (en) | 2006-03-09 |
AR040445A1 (en) | 2005-04-06 |
CA2485545A1 (en) | 2003-12-31 |
EP1529035A1 (en) | 2005-05-11 |
WO2004000818A1 (en) | 2003-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200407985B (en) | 1-(4-Piperidinyl) benzimidazolones as histamine H3antagonists. | |
AU2003257094A1 (en) | Substituted benzimidazole compounds | |
AP2331A (en) | Triazole derivatives as vasopressin antagonists. | |
EP1828143A4 (en) | 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors | |
IL165611A0 (en) | 1H-1,2,4-triazole-3-carboxamide derivatives as cannabinoid-cb1 receptor ligands | |
EP1954683A4 (en) | 2-(phenyl or heterocyclic)-1h-phenantrho(9,10-d)imidazoles as mpges-1 inhibitors | |
PL368672A1 (en) | Novel 1,2,4-triazole compound | |
AU2002349754A1 (en) | Novel 1,2,4-triazole compound | |
AU2003274650A1 (en) | Acoustic cardiac assessment | |
AU2003241535A1 (en) | Work force management application | |
AU2003265681A1 (en) | Indoles having anti-diabetic activity | |
AU2003211424A1 (en) | Nitrogen-containing heterocyclic compound | |
AU2003219410A1 (en) | Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors | |
PL373889A1 (en) | (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists | |
AU2003263815A1 (en) | Anti-tip rack for long handled tools | |
WO2004077198A8 (en) | Activity based costing underwriting tool | |
AU2003211385A1 (en) | Azole compounds | |
IL184048A0 (en) | Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists | |
AU2003281039A1 (en) | Imidazole derivative | |
AU2003222206A1 (en) | Novel benzimidazole compounds | |
AU2003237945A1 (en) | Crystalline (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl)-benzimidazole, and the use thereof as antithrombotic agents | |
AU2003296393A1 (en) | Factor xa inhibitors | |
AU2003254902A1 (en) | Myocardial cell protecting agents | |
AU2003215804A1 (en) | Antidiabetic agents | |
AU2002953019A0 (en) | Azole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |